GILEAD SCIENCES INC Insider Trading for July 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for July 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | M | 26.62 | 45,000 | 1,197,675 | 0 | |
| Jul 30 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 90.56 | 45,000 | 4,075,403 | 0 | 45 K to 0 (-100.00 %) |
| Jul 30 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Buy | M | 26.62 | 45,000 | 1,197,675 | 45,000 | 0 to 45 K |
| Jul 23 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 14.34 | 5,000 | 71,688 | 76,000 | |
| Jul 23 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 90.16 | 1,196 | 107,827 | 42,405 | 43.6 K to 42.4 K (-2.74 %) |
| Jul 23 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 89.52 | 3,804 | 340,515 | 43,601 | 47.4 K to 43.6 K (-8.02 %) |
| Jul 23 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 14.34 | 5,000 | 71,688 | 47,405 | 42.4 K to 47.4 K (+11.79 %) |
| Jul 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 16,728 | 451,489 | 40,992 | |
| Jul 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 86.45 | 16,728 | 1,446,074 | 30,705 | 47.4 K to 30.7 K (-35.27 %) |
| Jul 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 16,728 | 451,489 | 47,433 | 30.7 K to 47.4 K (+54.48 %) |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 23.76 | 1,633 | 38,792 | 166,367 | |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 23.60 | 29,367 | 693,061 | 5,000 | |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 85.04 | 1,300 | 110,557 | 126,694 | 128 K to 126.7 K (-1.02 %) |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 83.94 | 700 | 58,757 | 127,994 | 128.7 K to 128 K (-0.54 %) |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 85.37 | 800 | 68,298 | 128,694 | 129.5 K to 128.7 K (-0.62 %) |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 84.97 | 7,400 | 628,773 | 129,494 | 136.9 K to 129.5 K (-5.41 %) |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 83.76 | 22,800 | 1,909,692 | 136,894 | 159.7 K to 136.9 K (-14.28 %) |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 23.76 | 1,633 | 38,792 | 159,694 | 158.1 K to 159.7 K (+1.03 %) |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 23.60 | 29,367 | 693,061 | 158,061 | 128.7 K to 158.1 K (+22.82 %) |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 703,133 | |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 85.40 | 18,100 | 1,545,678 | 4,429,387 | 4.4 M to 4.4 M (-0.41 %) |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 85.01 | 92,300 | 7,846,728 | 4,447,487 | 4.5 M to 4.4 M (-2.03 %) |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 83.96 | 30,225 | 2,537,555 | 4,539,787 | 4.6 M to 4.5 M (-0.66 %) |
| Jul 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |
| Jul 02 2014 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 1,011 | 0 | 17,355 | |
| Jul 02 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 791 | 0 | 23,895 | |
| Jul 02 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 26.99 | 5,000 | 134,950 | 40,000 | |
| Jul 02 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 83.65 | 5,000 | 418,250 | 15,641 | 20.6 K to 15.6 K (-24.22 %) |
| Jul 02 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 26.99 | 5,000 | 134,950 | 20,641 | 15.6 K to 20.6 K (+31.97 %) |
| Jul 02 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 83.98 | 10,400 | 873,403 | 46,774 | 57.2 K to 46.8 K (-18.19 %) |